BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brown AW, Nathan SD. The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis. Annals ATS 2018;15:3-10. [DOI: 10.1513/annalsats.201703-244fr] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Nunes FS, Pastre J, Brown AW, Shlobin OA, King C, Weir NA, Nathan SD. Does 1-minute walk test predict results of 6-minute walk test in patients with idiopathic pulmonary fibrosis? Sarcoidosis Vasc Diffuse Lung Dis 2021;38:e2021005. [PMID: 33867792 DOI: 10.36141/svdld.v38i1.9258] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Scherr A, Schumann DM, Karakioulaki M, Franchetti L, Strobel W, Zellweger M, Tamm M, Stolz D. Endothelial dysfunction is not a predictor of outcome in chronic obstructive pulmonary disease. Respir Res 2020;21:90. [PMID: 32312273 DOI: 10.1186/s12931-020-01345-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wang J, Zang Y, Wu Q, She Y, Xu H, Zhang J, Cai S, Li Y, Zhang Z. Predicting Adverse Events During Six-Minute Walk Test Using Continuous Physiological Signals. Front Physiol 2022;13:887954. [DOI: 10.3389/fphys.2022.887954] [Reference Citation Analysis]
4 De Lorenzo R, Magnaghi C, Cinel E, Vitali G, Martinenghi S, Mazza MG, Nocera L, Cilla M, Damanti S, Compagnone N, Ferrante M, Conte C, Benedetti F, Ciceri F, Rovere-Querini P. A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors. Front Med (Lausanne) 2022;9:781410. [PMID: 35280880 DOI: 10.3389/fmed.2022.781410] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Allado E, Poussel M, Albuisson E, Paysant J, Temperelli M, Hily O, Moussu A, Benhajji N, Gauchard GC, Chenuel B. Physical Activity Capacity Assessment of Patients with Chronic Disease and the Six-Minute Walk Test: A Cross-Sectional Study. Healthcare 2022;10:758. [DOI: 10.3390/healthcare10050758] [Reference Citation Analysis]
6 Hegazy FA, Mohamed Kamel SM, Abdelhamid AS, Aboelnasr EA, Elshazly M, Hassan AM. Effect of postoperative high load long duration inspiratory muscle training on pulmonary function and functional capacity after mitral valve replacement surgery: A randomized controlled trial with follow-up. PLoS One 2021;16:e0256609. [PMID: 34449776 DOI: 10.1371/journal.pone.0256609] [Reference Citation Analysis]
7 Agarwala P, Salzman SH. Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement. Chest 2020;157:603-11. [PMID: 31689414 DOI: 10.1016/j.chest.2019.10.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
8 Baddini-Martinez JA. Six-minute walk test in patients with idiopathic pulmonary fibrosis. J Bras Pneumol 2018;44:257-8. [PMID: 30328922 DOI: 10.1590/S1806-37562018000040001] [Reference Citation Analysis]
9 Sekikawa K, Aizawa F, Sekikawa N, Egami M, Kanda N, Abe K, Matsumura Y, Umayahara Y, Kawae T. Twenty-four-hour ambulatory oximetry monitoring in a patient with idiopathic pulmonary fibrosis for assisting in the discharge instruction on activities of daily living: a case report. J Phys Ther Sci 2020;32:768-71. [PMID: 33281294 DOI: 10.1589/jpts.32.768] [Reference Citation Analysis]
10 Lin CY, Hsieh MH, Fang YF, Peng CW, Ju JS, Lo YL, Lin SM, Lin HC. Predicting mortality in non-cystic fibrosis bronchiectasis patients using distance-saturation product. Ann Med 2021;53:2034-40. [PMID: 34761709 DOI: 10.1080/07853890.2021.1999490] [Reference Citation Analysis]
11 Chandel A, Pastre J, Valery S, King CS, Nathan SD. Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis. Thorax 2022:thoraxjnl-2021-218440. [PMID: 35332096 DOI: 10.1136/thoraxjnl-2021-218440] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Timofte I, Tonelli A, Diaz-Abad M, Verceles A, Ladikos N, Iacono A, Terrin ML, Wijesinha M, Akindipe O, Baz M. Gait-speed and oxygen flow during six-minute walk test predicts mortality in patients with advanced lung disease. Monaldi Arch Chest Dis 2020;90. [PMID: 32072801 DOI: 10.4081/monaldi.2020.1186] [Reference Citation Analysis]
13 Dejcman D, Skowasch D, Pizarro C, Krause A, Thomas D, Schäfer VS. Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options. Curr Rheumatol Rev 2021;17:17-28. [PMID: 32888273 DOI: 10.2174/1573397116666200905122757] [Reference Citation Analysis]
14 Maher TM, Kreuter M, Lederer DJ, Brown KK, Wuyts W, Verbruggen N, Stutvoet S, Fieuw A, Ford P, Abi-Saab W, Wijsenbeek M. Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2). BMJ Open Respir Res 2019;6:e000422. [PMID: 31179008 DOI: 10.1136/bmjresp-2019-000422] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
15 Mancuzo EV, Soares MR, Pereira CAC. Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil. J Bras Pneumol 2018;44:267-72. [PMID: 30328926 DOI: 10.1590/S1806-37562018000000049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, Hashmi SK, Prata L, Masternak MM, Kritchevsky SB, Musi N, Kirkland JL. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine 2019;40:554-63. [PMID: 30616998 DOI: 10.1016/j.ebiom.2018.12.052] [Cited by in Crossref: 324] [Cited by in F6Publishing: 302] [Article Influence: 108.0] [Reference Citation Analysis]
17 Prior TS, Hilberg O, Shaker SB, Davidsen JR, Hoyer N, Birring SS, Bendstrup E. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis. BMC Pulm Med 2019;19:255. [PMID: 31856786 DOI: 10.1186/s12890-019-1018-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
18 Li J, Li X, Deng M, Liang X, Wei H, Wu X. Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors. BMJ Open 2022;12:e055077. [PMID: 35705338 DOI: 10.1136/bmjopen-2021-055077] [Reference Citation Analysis]